Rotate injection sites systematically, avoid injecting into areas with existing skin problems, and ensure the skin is clean and dry before injection
Trials seldom report outcomes before week 4, so early-week estimates are approximations
PRIMA-1 and PRIMA-1(Met) (APR-246): from mutant/wild type p53 reactivation to unexpected mechanisms underlying their potent anti-tumor effect in combinatorial therapies
Because no long-duration human studies exist, the consequences of months or years of repeated dosing on the immune system, hormonal axes, or fibrotic tissue remodeling are simply unknown
Narendra DP, Jin SM, Tanaka A, Suen DF, Gautier CA, Shen J, et al
Used for liver support, neurological health, skin brightening, heavy metal detox, and as adjunctive therapy in chronic illness management